Ema Ozaki

1.7k total citations · 1 hit paper
23 papers, 1.3k citations indexed

About

Ema Ozaki is a scholar working on Ophthalmology, Molecular Biology and Neurology. According to data from OpenAlex, Ema Ozaki has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Ophthalmology, 11 papers in Molecular Biology and 6 papers in Neurology. Recurrent topics in Ema Ozaki's work include Retinal Diseases and Treatments (12 papers), Retinal Development and Disorders (5 papers) and Ocular Diseases and Behçet’s Syndrome (5 papers). Ema Ozaki is often cited by papers focused on Retinal Diseases and Treatments (12 papers), Retinal Development and Disorders (5 papers) and Ocular Diseases and Behçet’s Syndrome (5 papers). Ema Ozaki collaborates with scholars based in Ireland, United States and United Kingdom. Ema Ozaki's co-authors include Sarah Doyle, Matthew Campbell, Marian M. Humphries, Peter Humphries, Anna‐Sophia Kiang, Paul F. Kenna, Ed C. Lavelle, G. Jane Farrar, Robert G. Salomon and Andrés Mori and has published in prestigious journals such as Nature Medicine, Nature Communications and The Journal of Immunology.

In The Last Decade

Ema Ozaki

23 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives

2015 343 citations Sarah Doyle, Ema Ozaki et al. Journal of Inflammation Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ema Ozaki Ireland	14	766	470	303	225	147	23	1.3k
Haibin Tian China	23	651 0.8×	397 0.8×	151 0.5×	154 0.7×	214 1.5×	79	1.4k
Benjamin J. Fowler United States	14	827 1.1×	847 1.8×	230 0.8×	126 0.6×	360 2.4×	32	1.7k
Xiu‐Miao Li China	21	1.7k 2.2×	304 0.6×	154 0.5×	90 0.4×	106 0.7×	57	2.3k
Gezhi Xu China	19	376 0.5×	623 1.3×	127 0.4×	176 0.8×	341 2.3×	77	1.1k
Kameran Lashkari United States	18	704 0.9×	822 1.7×	177 0.6×	86 0.4×	550 3.7×	59	1.6k
Rosalia D’Angelo Italy	26	661 0.9×	297 0.6×	111 0.4×	65 0.3×	145 1.0×	71	1.3k
Chun Yang Canada	21	964 1.3×	259 0.6×	180 0.6×	44 0.2×	172 1.2×	55	1.6k
Souska Zandi Switzerland	23	440 0.6×	738 1.6×	118 0.4×	95 0.4×	492 3.3×	59	1.4k
Diego G. Espinosa‐Heidmann United States	19	668 0.9×	1.2k 2.5×	184 0.6×	249 1.1×	479 3.3×	31	1.6k
Samy Omri Canada	18	493 0.6×	869 1.8×	102 0.3×	149 0.7×	537 3.7×	30	1.3k

Countries citing papers authored by Ema Ozaki

Since Specialization

Citations

This map shows the geographic impact of Ema Ozaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ema Ozaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ema Ozaki more than expected).

Fields of papers citing papers by Ema Ozaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ema Ozaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ema Ozaki. The network helps show where Ema Ozaki may publish in the future.

Co-authorship network of co-authors of Ema Ozaki

This figure shows the co-authorship network connecting the top 25 collaborators of Ema Ozaki. A scholar is included among the top collaborators of Ema Ozaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ema Ozaki. Ema Ozaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sullivan, Graeme P., Kevin P. Byrne, Yasmina Hernandez-Santana, et al.. (2025). Endothelial IL-36 receptor activation promotes vascular stability to limit pathological microvessel permeability in the CNS. Cell Reports. 44(11). 116549–116549. 1 indexed citations

Ozaki, Ema, et al.. (2022). Multiomic Mass Spectrometry Imaging to Advance Future Pathological Understanding of Ocular Disease. Metabolites. 12(12). 1239–1239. 4 indexed citations

Ozaki, Ema, Chris Greene, Michael Carty, et al.. (2022). SARM1 Promotes Photoreceptor Degeneration in an Oxidative Stress Model of Retinal Degeneration. Frontiers in Neuroscience. 16. 852114–852114. 5 indexed citations

Ozaki, Ema, Conor P. Delaney, Matthew Campbell, & Sarah Doyle. (2022). Minocycline suppresses disease-associated microglia (DAM) in a model of photoreceptor cell degeneration. Experimental Eye Research. 217. 108953–108953. 25 indexed citations

Ozaki, Ema, Nuno Neto, Paul F. Kenna, et al.. (2020). SARM1 deficiency promotes rod and cone photoreceptor cell survival in a model of retinal degeneration. Life Science Alliance. 3(5). e201900618–e201900618. 34 indexed citations

Mulfaul, Kelly, Ema Ozaki, Nilisha Fernando, et al.. (2020). Toll-like Receptor 2 Facilitates Oxidative Damage-Induced Retinal Degeneration. Cell Reports. 30(7). 2209–2224.e5. 45 indexed citations

Kenna, Paul F., Marian M. Humphries, Anna‐Sophia Kiang, et al.. (2020). Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. BMJ Open Ophthalmology. 5(1). e000462–e000462. 11 indexed citations

Augustine, Josy, Sofia Pavlou, Imran Ali, et al.. (2019). IL-33 deficiency causes persistent inflammation and severe neurodegeneration in retinal detachment. Journal of Neuroinflammation. 16(1). 251–251. 38 indexed citations

Hudson, Natalie, A. Hopkins, Chris Greene, et al.. (2019). Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophy. JCI Insight. 4(15). 50 indexed citations

10.

Brennan, Kiva, Eamon P. Breen, Emma Connolly, et al.. (2018). Type 1 IFN Induction by Cytosolic Nucleic Acid Is Intact in Neonatal Mononuclear Cells, Contrasting Starkly with Neonatal Hyporesponsiveness to TLR Ligation Due to Independence from Endosome-Mediated IRF3 Activation. The Journal of Immunology. 201(4). 1131–1143. 11 indexed citations

11.

Theodoropoulou, Sofia, David A. Copland, Jian Liu, et al.. (2016). Interleukin‐33 regulates tissue remodelling and inhibits angiogenesis in the eye. The Journal of Pathology. 241(1). 45–56. 50 indexed citations

12.

Doyle, Sarah, et al.. (2015). Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives. Journal of Inflammation Research. 8. 15–15. 343 indexed citations breakdown →

13.

Doyle, Sarah, Francisco J. López, Kiva Brennan, et al.. (2015). IL-18 Immunotherapy for Neovascular AMD: Tolerability and Efficacy in Nonhuman Primates. Investigative Ophthalmology & Visual Science. 56(9). 5424–5424. 33 indexed citations

14.

Campbell, Matthew, Sarah Doyle, Ema Ozaki, et al.. (2014). An Overview of the Involvement of Interleukin-18 in Degenerative Retinopathies. Advances in experimental medicine and biology. 801. 409–415. 7 indexed citations

15.

Ozaki, Ema, Matthew Campbell, Anna‐Sophia Kiang, et al.. (2014). Inflammation in Age-Related Macular Degeneration. Advances in experimental medicine and biology. 801. 229–235. 37 indexed citations

16.

Yuan, Hsiangkuo, Christy Wilson, Jun Xia, et al.. (2014). Plasmonics-enhanced and optically modulated delivery of gold nanostars into brain tumor. Nanoscale. 6(8). 4078–4082. 47 indexed citations

17.

Campbell, Matthew, Finnian Hanrahan, Oliviero L. Gobbo, et al.. (2012). Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injury. Nature Communications. 3(1). 849–849. 91 indexed citations

18.

Doyle, Sarah, Matthew Campbell, Ema Ozaki, et al.. (2012). NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nature Medicine. 18(5). 791–798. 348 indexed citations

19.

Campbell, Matthew, Marian M. Humphries, Anna‐Sophia Kiang, et al.. (2011). Systemic low‐molecular weight drug delivery to pre‐selected neuronal regions. EMBO Molecular Medicine. 3(4). 235–245. 31 indexed citations

20.

Campbell, Matthew, Ema Ozaki, & Peter Humphries. (2010). Systemic delivery of therapeutics to neuronal tissues: a barrier modulation approach. Expert Opinion on Drug Delivery. 7(7). 859–869. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact